| Business Summary | | Rochester
Medical
Corporation
develops,
manufactures,
and
markets
latex-free
urinary
continence
and
urine
drainage
care
products
for
the
home
care
and
acute/extended
care
markets.
The
Company's
home
care
products
include
its
Femsoft
Insert,
a
soft,
liquid-filled,
conformable
urethral
insert
for
managing
female
stress
urinary
incontinence,
a
line
of
male
external
catheters
for
managing
male
urinary
incontinence,
and
a
line
of
intermittent
catheters
for
managing
both
male
and
female
urinary
retention.
The
Company's
acute/extended
care
products
include
a
line
of
standard
Foley
catheters
and
its
Release-NF
Catheter,
an
antibacterial
Foley
catheter
to
reduce
the
incidence
of
hospital
acquired
urinary
tract
infection. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Rochester
Medical
Corp.
develops,
manufactures,
and
markets
a
broad
line
of
innovative,
technologically
enhanced
latex-free
urinary
continence
and
urinary
drainage
management
care
products
to
the
home
care
and
acute
care
markets.
For
the
nine
months
ended
6/01,
net
sales
fell
less
than
1%
to
$6.1
million.
Net
loss
fell
43%
to
$2.2
million.
Revenues
reflect
lower
sales
to
ConvaTec.
Lower
loss
reflects
personnel
reductions
and
non-recurring
costs
associated
with
the
FEMSOFT
INSERT. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Anthony Conway, 56 Chairman,
CEO, Pres and Sec. | $197K | Philip Conway, 44 VP
of Production Technologies | 137K | Martyn Sholtis, 41 VP
of Sales and Marketing | -- | Dara Horner, 42 VP,
FEMSOFT Marketing | 140K | Richard Fryar, 53 VP
of R&D | 137K | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|